Telemedycyna Polska SA
WSE:TMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samhallsbyggnadsbolaget I Norden AB
STO:SBB B
|
SE |
|
DDS Inc
TSE:3782
|
JP |
|
M
|
Mukand Ltd
NSE:MUKANDLTD
|
IN |
|
Mobile Factory Inc
TSE:3912
|
JP |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (8.6), the stock would be worth zł0 (100% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | zł0.62 |
0%
|
| Industry Average | 8.6 | zł0 |
-100%
|
| Country Average | 8.6 | zł0 |
-100%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| PL |
T
|
Telemedycyna Polska SA
WSE:TMP
|
8.5m PLN | 0 | 0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.2B USD | 14.1 | 55.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.3B EUR | 7.7 | 13.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.4B USD | 0 | 12.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.1B EUR | 9.9 | 19.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.8B EUR | 9 | 23.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD | 12.2 | 25.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 11.8 | 21.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 5.4 | 11.3 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -31 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.1B USD | 7.1 | 13.6 |
Market Distribution
Other Multiples
Telemedycyna Polska SA
Glance View
Telemedycyna Polska SA engages in the provision of medical treatment. The company is headquartered in Katowice, Woj. Slaskie. The company went IPO on 2010-08-18. The company operates Kardiotele system which enables cardiologic care and checks such as electrocardiogram (EKG) through telephone connection. Kariotele is addressed to individuals, as well as to nursing homes and rehabilitation centers. As of December 31, 2011, the Company operated one wholly owned subsidiary, Centrum Nadzoru Kardiologicznego Kardiofon Sp. z o.o.
